Lun S - Search Results

1

The preclinical candidate indole-2-carboxamide improves immune responses to Mycobacterium tuberculosis infection in healthy subjects and individuals with type 2 diabetes.

Cao R, Islamoglu H, Teskey G, Gyurjian K, Abrahem R, Onajole OK, Lun S, Bishai W, Kozikowski AP, Fraix MP, Sathananthan A, Zhong L, Stec J, Venketaraman V. Cao R, et al. Among authors: lun s. Int Microbiol. 2020 May;23(2):161-170. doi: 10.1007/s10123-019-00086-0. Epub 2019 Jun 19. Int Microbiol. 2020. PMID: 31218537

2

Characterization of a novel cell wall-anchored protein with carboxylesterase activity required for virulence in Mycobacterium tuberculosis.

Lun S, Bishai WR. Lun S, et al. J Biol Chem. 2007 Jun 22;282(25):18348-18356. doi: 10.1074/jbc.M700035200. Epub 2007 Apr 11. J Biol Chem. 2007. PMID: 17428787 Free article.

3

Extrapulmonary dissemination of Mycobacterium bovis but not Mycobacterium tuberculosis in a bronchoscopic rabbit model of cavitary tuberculosis.

Nedeltchev GG, Raghunand TR, Jassal MS, Lun S, Cheng QJ, Bishai WR. Nedeltchev GG, et al. Among authors: lun s. Infect Immun. 2009 Feb;77(2):598-603. doi: 10.1128/IAI.01132-08. Epub 2008 Dec 8. Infect Immun. 2009. PMID: 19064634 Free PMC article.

4

Targeting the chromosome partitioning protein ParA in tuberculosis drug discovery.

Nisa S, Blokpoel MC, Robertson BD, Tyndall JD, Lun S, Bishai WR, O'Toole R. Nisa S, et al. Among authors: lun s. J Antimicrob Chemother. 2010 Nov;65(11):2347-58. doi: 10.1093/jac/dkq311. Epub 2010 Sep 1. J Antimicrob Chemother. 2010. PMID: 20810423 Free PMC article.

5

Pyrido[1,2-a]benzimidazole-based agents active against tuberculosis (TB), multidrug-resistant (MDR) TB and extensively drug-resistant (XDR) TB.

Pieroni M, Tipparaju SK, Lun S, Song Y, Sturm AW, Bishai WR, Kozikowski AP. Pieroni M, et al. Among authors: lun s. ChemMedChem. 2011 Feb 7;6(2):334-42. doi: 10.1002/cmdc.201000490. Epub 2011 Jan 21. ChemMedChem. 2011. PMID: 21259445 Free PMC article.

6

Alterations in phospholipid catabolism in Mycobacterium tuberculosis lysX mutant.

Maloney E, Lun S, Stankowska D, Guo H, Rajagoapalan M, Bishai WR, Madiraju MV. Maloney E, et al. Among authors: lun s. Front Microbiol. 2011 Feb 11;2:19. doi: 10.3389/fmicb.2011.00019. Front Microbiol. 2011. PMID: 21552395 Free PMC article.

7

Evaluation of gyrase B as a drug target in Mycobacterium tuberculosis.

Chopra S, Matsuyama K, Tran T, Malerich JP, Wan B, Franzblau SG, Lun S, Guo H, Maiga MC, Bishai WR, Madrid PB. Chopra S, et al. Among authors: lun s. J Antimicrob Chemother. 2012 Feb;67(2):415-21. doi: 10.1093/jac/dkr449. Epub 2011 Nov 2. J Antimicrob Chemother. 2012. PMID: 22052686 Free PMC article.

8

Successful shortening of tuberculosis treatment using adjuvant host-directed therapy with FDA-approved phosphodiesterase inhibitors in the mouse model.

Maiga M, Agarwal N, Ammerman NC, Gupta R, Guo H, Maiga MC, Lun S, Bishai WR. Maiga M, et al. Among authors: lun s. PLoS One. 2012;7(2):e30749. doi: 10.1371/journal.pone.0030749. Epub 2012 Feb 3. PLoS One. 2012. PMID: 22319585 Free PMC article.

9

Isoniazid resistance without a loss of fitness in Mycobacterium tuberculosis.

Lee JH, Ammerman NC, Nolan S, Geiman DE, Lun S, Guo H, Bishai WR. Lee JH, et al. Among authors: lun s. Nat Commun. 2012 Mar 20;3:753. doi: 10.1038/ncomms1724. Nat Commun. 2012. PMID: 22434196 Free PMC article.

10

Risk of tuberculosis reactivation with tofacitinib (CP-690550).

Maiga M, Lun S, Guo H, Winglee K, Ammerman NC, Bishai WR. Maiga M, et al. Among authors: lun s. J Infect Dis. 2012 Jun;205(11):1705-8. doi: 10.1093/infdis/jis269. Epub 2012 Apr 3. J Infect Dis. 2012. PMID: 22474037 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

190 results

Search Page